First Participants Treated In AD-214 Phase I Clinical Trial
23 July 2020 AdAlta Limited (ASX:1AD), the clinical stage biotechnology company developing novel therapeutic products from its i-body platform is pleased to announce that the first healthy participants in the blinded Phase I clinical trial of AD-214 have…
OMX Solutions Celebrate 200 Implantations of TMJ Joint Replacement Prosthesis
15 July 2020 Melbourne based design house for custom medical devices for oral and maxillofacial applications, OMX Solutions Pty Ltd is delighted to announce the 200th implantation of its custom designed temporomandibular joint (TMJ) replacement device, the OMX…
2020 Australia’s STEM Workforce Report
23 July 2020 Via Australia’s Chief Scientist. The second Australia’s STEM Workforce report once again provides a comprehensive analysis of Australia’s Science, Technology, Engineering and Mathematics (STEM) trained workforce. The report builds on data from the 2016 report, updating…
Global 3D printing partnership to boost local manufacturing
23 July 2020 RMIT University is partnering with Europe’s leading 3D printing institute to support the transformation of Australian manufacturing. The memorandum of understanding with Fraunhofer Institute for Material and Beam Technology IWS covers staff and student exchanges…
JobKeeper extension, eligibility and rate updates
21 July 2020 Keep up to date with the latest updates via the Federal Government. On 21 July, the Government announced it is extending the JobKeeper Payment until 28 March 2021 and is targeting support to those organisations…
Crux Biolabs make Mountain Highway Business Park home
21 July 2020 This week Crux Biolabs is moving to a larger lab premises at the Mountain Highway Business Park in Bayswater. Crux’s growth since obtaining NATA accreditation to ISO 17025 in early 2019 has meant that…
General advice on face masks and coverings for Victoria
Date posted 21 July 2020 For the most up-to-date information, please visit the Department of Health and Human Services Coronavirus Advice webpage. For information targeted to businesses, see “Face masks in the workplace”. If you live within metropolitan…
Face masks in the workplace
Date posted: 21 July 2020 For the most up-to-date information, please visit the Business Victoria Coronavirus webpage. For general advice, see “General advice on face masks and coverings for Victoria”. From 11.59pm on Wednesday 22 July, people living…
UniQuest and CSL Limited partner to develop potential treatment for Sjogren’s Syndrome
20 July 2020 UniQuest, The University of Queensland’s (UQ’s) technology transfer company has announced it will partner with CSL to develop and commercialise UQ’s antigen specific immune tolerance induction (ASITI) technology for the treatment of Sjogren’s Syndrome. Under…
Noxopharm: Independent Data Confirms Idronoxil Achieves Major Industry Goal of Converting ‘COLD’ Tumours to ‘HOT’ Tumours
20 July 2020 Key points: Pre-clinical data indicates that idronoxil (active ingredient in Veyonda®) achieves major goal in converting immunologically ‘COLD’ tumours to ‘HOT’ ‘COLD’ to ‘HOT’ conversion restores cancer-fighting immune cells to tumours, seen as a prerequisite…
MTPConnect and MRFF BioMedTech Horizons Funds 21 Projects In Round 3
20 July 2020 Delivered by MTPConnect, the Australian Government’s $45 million BioMedTech Horizons program is an initiative to support innovative collaborative health technologies, drive discoveries towards proof-of-concept and commercialisation that address key health challenges as well as maximise…
AdAlta Receives US FDA Regulatory Advice Guiding AD-214 Development
20 July 2020 Highlights: Supportive US Food and Drug Administration (FDA) advice received in relation to AdAlta’s lead therapeutic candidate, AD-214 Pre-clinical program and Phase I trial design for AD-214 deemed sufficient to support an Investigational New Drug…
